AHA Coding Clinic® for ICD-10-CM and ICD-10-PCS - 2024 Issue 4; ICD-10-PCS New/Revised Codes Section X – New Technology
Marnetegragene Autotemcel
In table XW1, Transfusion of Anatomical Regions, substance value 7 Marnetegragene Autotemcel was added to the body part values 3 Peripheral Vein and 4 Central Vein.Body Part Approach Device/Substance/Technology Qualifier 3 Peripheral Vein 4 Central Vein 3 Percutaneous 7 Marnetegragene Autotemcel A New Technology Group 10 Marnetegragene autotemcel (RP-L201) is an autologous gene therapy that uses the patient’s hematopoietic stem cells to treat severe leukocyte adhesion deficiency Type 1 (LAD-1). LAD-1 is an extremely rare genetic condition that causes the loss of immune response that results in recurrent infections. ...
Subscribe or sign in to view the full article.
Article Overview
This article explains a coding update in ICD-10-PCS related to marnetegragene autotemcel and provides background on the therapy itself. It is useful for inpatient coders, HIM professionals, and others tracking PCS table changes and emerging gene-therapy-related coding updates. The article gives a high-level clinical context for the treatment and identifies where the new technology value was added within the relevant table.
Why This Topic Matters
Updates involving new technology values can affect inpatient procedure coding and code assignment workflows. This article helps readers recognize that a specific gene therapy has been incorporated into the PCS framework and understand the general clinical context behind the update.
Article Sections
-
ICD-10-PCS table update
Covers the procedural table change and the affected body part values within the inpatient coding system. The section focuses on the addition of a new technology-related value.
-
Clinical overview
Provides a brief description of the therapy and the condition it is intended to address. The section offers general background on the treatment’s purpose and clinical setting.
What You Will Learn
- Which coding system the update affects
- How the article frames the new technology-related table change
- The general clinical context for the therapy
- Why the update may be relevant to inpatient coding workflows
Who Should Read This
- Inpatient medical coders
- HIM professionals
- Coding auditors
- Revenue cycle teams
- Clinical documentation specialists
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com